{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":55,"n_cols":5,"rows_kept":55,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[11,2,11,3],[15,2,15,3],[15,4,15,5],[16,2,16,3],[16,4,16,5],[17,2,17,3],[17,4,17,5],[18,2,18,3],[19,2,19,3],[20,2,20,3],[21,2,21,3],[22,2,22,3],[50,2,50,3],[51,2,51,3],[54,2,54,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910717381003321"]
[null,null,"Autore",null,"Gaffney Jonathan M."]
[null,null,"Titolo",null,"\"Tracing papers\" : a comparison of COVID-19 data privacy bills / / Jonathan M. Gaffney"]
[null,null,"Pubbl/distr/stampa",null,"Washington, District of Columbia : , : Congressional Research Service, , 2020"]
[{"$nulls":4},"©2020"]
[null,null,"Edizione",null,"[[Library of Congress public edition].]"]
[null,null,"Descrizione fisica",null,"1 online resource (5 pages)"]
[null,null,"Collana",null,"Legal sidebar"]
[null,null,"Disciplina",null,"614.592414"]
[null,null,"Soggetti",null,"COVID-19 (Disease)"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","The CRS web page provides access to all versions published since 2018 in accordance with P.L. 115-141."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,"2.","Record Nr.",null,"UNINA9910785176703321"]
[null,null,"Autore",null,"Holmqvist Gunnar N"]
[null,null,"Titolo",null,"Statins [[electronic resource] ] : Indications and Uses, Safety and Modes of Action"]
[null,null,"Pubbl/distr/stampa",null,"New York, : Nova Science Publishers, Inc., 2008"]
[null,null,"ISBN",null,"1-60876-345-5"]
[null,null,"Descrizione fisica",null,"1 online resource (219 p.)"]
[null,null,"Disciplina",null,"615/.718"]
[null,null,"Soggetti",null,"Anticholesteremic agents"]
[{"$nulls":4},"Statins (Cardiovascular agents)"]
[{"$nulls":4},"Lipoproteins, LDL"]
[{"$nulls":4},"Anticholesteremic Agents"]
[{"$nulls":4},"Vascular Diseases"]
[{"$nulls":4},"Cholesterol"]
[{"$nulls":4},"Enzyme Inhibitors"]
[{"$nulls":4},"Heart Diseases"]
[{"$nulls":4},"Cholesterol, LDL"]
[{"$nulls":4},"Hydroxymethylglutaryl-CoA Reductase Inhibitors"]
[{"$nulls":4},"Myocardial Ischemia"]
[{"$nulls":4},"Sterols"]
[{"$nulls":4},"Hypolipidemic Agents"]
[{"$nulls":4},"Lipoproteins"]
[{"$nulls":4},"Cardiovascular Diseases"]
[{"$nulls":4},"Molecular Mechanisms of Pharmacological Action"]
[{"$nulls":4},"Antimetabolites"]
[{"$nulls":4},"Proteins"]
[{"$nulls":4},"Lipid Regulating Agents"]
[{"$nulls":4},"Lipids"]
[{"$nulls":4},"Diseases"]
[{"$nulls":4},"Pharmacologic Actions"]
[{"$nulls":4},"Membrane Lipids"]
[{"$nulls":4},"Therapeutic Uses"]
[{"$nulls":4},"Chemical Actions and Uses"]
[{"$nulls":4},"Amino Acids, Peptides, and Proteins"]
[{"$nulls":4},"Health & Biological Sciences"]
[{"$nulls":4},"Pharmacy, Therapeutics, & Pharmacology"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,"Nota di contenuto",null,"Statin therapy for coronary artery disease beyond lipid lowering effect / Teruo Inoue, Koichi Node -- Side effects of statins in monotherapy / Helmut Sinzinger, Bernhard A. Peskar -- Preliminary findings about the trends of the renal hemodynamics and the proxies of cardiovascular risk during a short course of atorvastatin therapy in essential hypertensives / Luigi Vernaglione -- Beneficial effects of addition of fenofibrate to statin therapy in patients with acute coronary syndrome after percutaneous coronary interventions / Hetal D. Shah ... [et al.] -- Non-lipid lowering effects of statins / A. Schmidt -- Statins in the therapy of acute coronary syndrome / Petr Ostadal -- Beneficial effects of addition of fenofibrate to statin therapy in patients with acute coronary syndrome after percutaneous coronary interventions / Hetal D. Shah ... [et al.] -- Bad HDL-C responders to statins / Dirk Devroey -- Beneficial effects of statins in systemic lupus erythematosus : molecular mechanism involved / Antonio G. Tristano."]